NCT03878849 2025-08-28
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer
Allarity Therapeutics
Phase 2 Recruiting
Clinical Trials
5 trialsNCT07120451 2025-08-13
Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker
Fudan University
Phase 2 Not yet recruiting
NCT05794659 2023-07-20
Cornerstone4
Aston Sci. Inc.
Phase 2 Not yet recruiting
NCT04556539 2021-05-12
Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 2 Unknown
NCT03611179 2018-08-02
Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer
Assiut University
Phase 2 Unknown